News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,438 Results
Type
Article (87722)
Company Profile (824)
Press Release (777873)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233164)
Career Advice (4142)
Deals (39830)
Drug Delivery (144)
Drug Development (91344)
Employer Resources (203)
FDA (18344)
Job Trends (17414)
News (397673)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (165)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (301)
Approvals (18429)
Artificial intelligence (573)
Autoimmune disease (127)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (185)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (60)
Breast cancer (579)
Cancer (4575)
Cardiovascular disease (403)
Career advice (3564)
Career pathing (39)
CAR-T (287)
CDC (59)
Cell therapy (776)
Cervical cancer (36)
Clinical research (76400)
Collaboration (1559)
Company closure (5)
Compensation (1049)
Complete response letters (64)
COVID-19 (2973)
CRISPR (93)
C-suite (720)
Cystic fibrosis (147)
Data (5677)
Decentralized trials (2)
Denatured (67)
Depression (129)
Diabetes (489)
Diagnostics (7158)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (220)
Earnings (99870)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134432)
Executive appointments (1009)
FDA (21138)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1414)
Gene editing (201)
Generative AI (59)
Gene therapy (614)
GLP-1 (1079)
Government (5415)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (270)
Immuno-oncology (33)
Indications (72)
Infectious disease (3240)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17941)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (639)
Lymphoma (355)
Machine learning (38)
Management (66)
Manufacturing (728)
MASH (164)
Medical device (14960)
Medtech (14998)
Mergers & acquisitions (22857)
Metabolic disorders (1271)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (316)
Neuropsychiatric disorders (82)
Neuroscience (2928)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (606)
Opinion (324)
Ovarian cancer (151)
Pain (181)
Pancreatic cancer (195)
Parkinson's disease (265)
Partnered (34)
Patents (459)
Patient recruitment (387)
Peanut (58)
People (66589)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23589)
Phase II (33168)
Phase III (24984)
Pipeline (3696)
Policy (317)
Postmarket research (3554)
Preclinical (10652)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (788)
Real estate (7435)
Recruiting (80)
Regulatory (28471)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (146)
Series A (229)
Series B (175)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1096)
Venture capital (76)
Weight loss (426)
Women's health (74)
Worklife (21)
Date
Today (147)
Last 7 days (625)
Last 30 days (2921)
Last 365 days (33399)
2025 (31974)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (84)
Alaska (7)
Arizona (323)
Arkansas (14)
Asia (51273)
Australia (9010)
California (10695)
Canada (3131)
China (1028)
Colorado (451)
Connecticut (478)
Delaware (320)
Europe (117880)
Florida (1568)
Georgia (346)
Hawaii (3)
Idaho (68)
Illinois (883)
India (62)
Indiana (514)
Iowa (22)
Japan (369)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1392)
Massachusetts (7940)
Michigan (339)
Minnesota (618)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2927)
New Mexico (32)
New York (2863)
North Carolina (1521)
North Dakota (10)
Northern California (5021)
Ohio (324)
Oklahoma (22)
Oregon (52)
Pennsylvania (2172)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4111)
Tennessee (164)
Texas (1671)
United States (38954)
Utah (322)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (901)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
There are 866,438 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
December 10, 2025
·
6 min read
Press Releases
ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science
December 10, 2025
·
4 min read
Press Releases
1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years
December 10, 2025
·
13 min read
Press Releases
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
December 10, 2025
·
7 min read
Press Releases
Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)
December 10, 2025
·
3 min read
Press Releases
Alligator Bioscience Comments on Henlius Receiving Regulatory Approval in China to Initiate Phase 2/3 Trials of HLX22 in HER2-Positive Breast Cancer
December 10, 2025
·
2 min read
Press Releases
Terns Announces Proposed Public Offering
December 10, 2025
·
5 min read
Press Releases
Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama
December 10, 2025
·
7 min read
Press Releases
Picard Celebrates Patient Living a World-Record of Over Eight Years with the SynCardia Total Artificial Heart
December 10, 2025
·
4 min read
Press Releases
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2025
December 10, 2025
·
2 min read
1 of 86,644
Next
